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Abstract
Background: The in vivo diagnosis of glanders relies on the highly sensitive complement fixation test (CFT).
Frequently observed false positive results are troublesome for veterinary authorities and cause financial losses to
animal owners. Consequently, there is an urgent need to develop a test with high specificity. Hence, a Western
blot assay making use of a partly purified lipopolysaccaride (LPS) containing antigen of three Burkholderia mallei
strains was developed. The test was validated investigating a comprehensive set of positive and negative sera
obtained from horses and mules from endemic and non endemic areas.
Results: The developed Western blot assay showed a markedly higher diagnostic specificity when compared to
the prescribed CFT and therefore can be used as a confirmatory test. However, the CFT remains the test of choice
for routine testing of glanders due to its high sensitivity, its feasibility using standard laboratory equipment and its
worldwide distribution in diagnostic laboratories.
Conclusions: The CFT should be amended by the newly validated Western blot to increase the positive likelihood
ratio of glanders serodiagnosis in non endemic areas or areas with low glanders prevalence. Its use for
international trade of horses and mules should be implemented by the OIE.
Background
Glanders, caused by Burkholderia (B.) mallei, is a highly
contagious disease in equines which is notifiable to the
World Organisation of Animal Health (OIE, Office
International des Epizooties). The disease is still ende-
mic in the Middle East, Asia and South America. Recent
outbreaks have been reported from Turkey, the United
Arabic Emirates, Iraq, Iran, India, Pakistan, Mongolia,
China, Brazil and most recently from Bahrain [1-11].
The distribution of glanders in Africa is unknown.
The diagnosis of B. mallei infection still relies on sero-
logical proof by agglutination test and complement fixa-
tion test (CFT), or proof of the presence of a specific
delayed hypersensitivity reaction after intracutaneous
application of mallein [12,13]. The CFT for glanders is
so far the only officially recognized serological test in
international trade of equidae. The CFT has a sensitivity
of at least 97% [14] but a notable number of unspecific,
false positive results occur [15-18]. False positive results
d u et oc r o s s - r e a c t i o n sm a yb es e e ni nh o r s e ss u f f e r i n g
from strangles, equine influenza or petechial fever. The
test can also not be applied on sera having so called
“anticomplementary activity”. In general, serological
tests may be negative in emaciated and chronically
debilitated animals suffering from glanders [16].
Glanders was eradicated from Western Europe, Aus-
tralia and North America in the last century applying a
rigorous culling of horses found positive in complement
fixation and mallein test [15,19]. These techniques are
useful in eradication programs with regard to specificity
and sensitivity [12]. However, in glanders free areas or
in areas with very low prevalence of glanders highly spe-
cific tests are needed to minimize the number of false
positive results [20]. Lipopolysaccharide (LPS) prepara-
tions have already been applied in Western blot analysis
or competition ELISA to detect anti-B. mallei antibodies
in serum of horses [20-22]. But current protocols for
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time consuming, sophisticated and hazardous for the
operator [23,24].
Here we describe a new Western blot assay based on
an easy to prepare LPS preparation containing antigen
from B. mallei, purified from soluble components. With
a specificity and a sensitivity of 100%, the assay can be
u s e dt oc o n f i r mp o s i t i v ea n da tt h es a m et i m et o
exclude false positive CFT results.
Methods
Production of hyperimmune sera in rabbits
One rabbit was immunized with a crude suspension (10
6
cfu/ml) of heat inactivated B .m a l l e i ,B .p s e u d o m a l l e i ,
B. cepacia, and Pseudomonas aeruginosa, respectively.
The strains used are given in Table 1. The first and sec-
ond immunizations (days 0 and 3) were done by intra-
cutaneous application of 10 doses of 0.2 ml (10
6 cfu/ml)
antigen without adjuvant distributed on the back.
Further, 5 immunizations were done by application of
0.5 ml (10
6 cfu/ml) in the ear vein (days 10, 17, 24, 31,
and 38). Seroconversion was monitored by CFT and
Western blot assay using the homologous antigen. The
final sera were collected 6 weeks after the first immuni-
zation (day 42). The animal experiment was authorized
by the government of Thuringia, Germany (registration
number 04-106/07).
Immunisation of a horse
To produce a panel of positive control sera, one horse
was immunized subcutaneously using a mixture of
crude suspensions of heat inactivated B. mallei strains
Mukteswar, Bogor and Zagreb (10
9 cfu/ml) adjuvanted
with aluminium hydroxide gel (Sigma Chemie GmbH,
Munich, Germany). Immunizations were performed
weekly for seven weeks with 7 doses of 1.5 ml antigen
containing increasing cell concentrations (10
3 cfu/ml to
10
9 cfu/ml). The titer was analysed in parallel by CFT
and Western blot analysis twice a week and for 10
weeks after the first immunization. The animal experi-
ment was authorized by the government of Thuringia,
Germany (registration number 04-105/07).
Samples
A total of 2,282 sera (group I) were collected from
different horse populations in several geographical areas
of Germany during 2006 to 2009.
These sera were considered negative for glanders
because Germany is free of the disease for more than 50
years.
The specificity testing was carried out with 305
samples (group II) randomly selected from group I
regarding the Mersenne Twister method by use of the
Software SPSS (SPSS Inc., Chicago, USA).
The sensitivity of the Western blot assay was tested
using 205 true positive sera (group III). Of these, 171 CFT
positive samples were collected from microbiologically or
clinically/mallein positive glanderous horses and mules in
Punjab, Pakistan (n = 59), Pernambuco, Brazil (n = 87),
and Dubai, United Arabic Emirates (n = 25). Included in
group III were additionally 21 and 13 sera from the
B. mallei-immunized horse and rabbit, respectively.
CFT
The CFT was performed according to the instructions of
the OIE Manual of Diagnostic tests and Vaccines for
Terrestrial Animals [13] using a certified, commercially
available antigen containing antigen from B. mallei
strains Bogor, Mukteswar, and Zagreb (cc-pro GmbH,
Oberdorla, Germany), and a complement and ready-to
use hemolytic system (Institut Virion/Serion GmbH,
Würzburg, Germany). Samples were considered negative
when 100% haemolysis occurred at 1:5 dilution,
suspicious when 25-75% haemolysis was seen at dilution
1:5 and positive when no haemolysis was detected at
dilution 1:5.
Antigen preparation for the Western blot assay
B. mallei strains Bogor, Zagreb and Mukteswar were
grown on blood agar plates over night at 37°C under
aerobic conditions. Details on the strains are given in
Table 1. For LPS purification, a 10-microliter loop full
of bacterial colony material was re-suspended thor-
oughly in 6 ml saline (0.9% NaCl, pH 7.0) up to a den-
sity comparable to McFarland scale 4.0. A volume of 3
ml of 37% formaldehyde was added to achieve a final
formaldehyde concentration of 12.3%. The suspension
was rigorously vortexed and subsequently swayed using
an orbital shaker (Polymax 1040, Heidolph Instruments
GmbH, Schwabach, Germany) over night at room tem-
perature. Controls for sterility confirmed inactivation of
bacteria. Cells were pelletized by centrifugation at 3.500
× g for 15 min and the supernatant was discarded. Solu-
ble components were removed by 3 consecutive centri-
fugation and washing steps with 9 ml phosphate
buffered saline (PBS, pH 7.0) shaking at 15 rpm for 10
minutes. The LPS-containing pellet was re-suspended in
Table 1 List of bacterial strains used in this study
Strain Source Geographic origin Species
Mukteswar Horse India Burkholderia mallei
Bogor Horse Indonesia Burkholderia mallei
Zagreb Horse Yugoslavia Burkholderia mallei
ATCC 23343 Human unknown Burkholderia pseudomallei
DSM 7288 unknown unknown Burkholderia cepacia
ATCC 9027 unknown unknown Pseudomonas aeruginosa
ATCC: American Type Culture Collection, Manassas, USA.
DSM: German Collection of Microorganisms and Cell Cultures, Braunschweig,
Germany.
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Page 2 of 69 ml PBS. Two further extraction steps by adding 1
volume of 37% formaldehyde into 2 volume re- sus-
pended cells in PBS were applied. By 3 consecutive
washing steps with PBS the soluble cell components and
the formaldehyde were removed. After the last washing
step the pellet was resuspended in PBS. Aliquots were
directly used for SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) and subsequent Western blot analysis. The
washing steps and the number of bacteria used for LPS
preparation were crucial for the efficient removal of
soluble components from the LPS-containing cell debris.
Optimal purification was achieved using 9 × 10
8 cells/ml
(McFarland scale 3) or less (data not shown).
The correct formation of a typical LPS ladder was
proofed by SDS-PAGE and silver staining before blot-
ting. For SDS-PAGE several dilutions from the prepared
LPS containing cell suspension in Laemmli Buffer
(Sigma, Munich, Germany) were loaded on a precast
denaturating 4-12% polyacrylamide gradient gel (Invitro-
gen, Karlsruhe, Germany) and separated at a constant
voltage of 200V for 50 min using the Xcell SureLock™
MiniCell (Invitrogen). Silver staining was carried out
with the SilverQuest™ silver staining kit (Invitrogen).
The LPS extracted from each of the B. mallei strains
showed the typical LPS ladder with no visible differ-
ences. We believe that soluble antigens are mainly
removed from the preparation but we are well aware,
that our antigen is not pure and contains other compo-
nents, like high molecular weight components (Figure 1).
The protein content of each antigen preparation was
below 0.5 mg/ml, measured by absorption at 280 nm
(Spectrophotometer NanoDrop 1000, Thermo Fisher
Scientific, Bonn, Germany). For further use, the antigen
preparations of the B. mallei strains Bogor, Zagreb and
Mukteswar were mixed equally.
Immuno blotting
For Western blotting analysis, 350 μl LPS-containing sus-
pension of B. mallei strains Bogor, Zagreb and Mukteswar
were separated on a precast preparative 4-12% polyacryla-
mide gradient gel (Invitrogen) as described above. LPS was
transferred to a 0.45 μm nitrocellulose membrane (Invitro-
gen) by blotting at constant 30V for 1 h using the Novex
®
Blot Module (Invitrogen). The membrane was blocked
overnight in Blocking Solution (Candor Bioscience,
Weißensberg, Germany). After three washing steps the
membrane was cut into strips of 3 mm and stored at -20°
C or was used for subsequent immunoblot analysis. Stripes
were incubated with equine or rabbit sera in a 1:50 dilu-
tion in Low Cross Buffer (Candor Bioscience) for 1.5 h at
room temperature followed by three washing steps in
washing buffer (Candor Bioscience) 20 min each. The
strips were then incubated for 1.5 h at room temperature
in Low Cross Buffer containing alkaline phosphatase-
conjugated rabbit anti-horse-IgG or goat anti-rabbit-IgG
(Sigma, Munich, Germany, 1:5,000). After three additional
washing steps, the strips were stained with NBT-BCIP
®
solution (Sigma). The immunostaining was stopped by
washing with distilled water after 10 minutes. The immu-
noblot was scored positive if the banding pattern of the B.
mallei LPS ladder within the region of 20 to 60 kDa was
clearly visible, scored suspicious if a weak color reaction
was detected, and scored negative if no reaction was seen
(Figure 2).
Results
CFT
A l l2 0 5s a m p l e so fg r o u pI I Iw e r ep o s i t i v er e s u l t i n gi na
sensitivity of 100%. Seventy of the 1,282 sera of group I
showed a false positive or suspicious CFT result result-
ing in a specificity of 94.5%.
Western blot assay
All 305 samples of group II were tested negative and all
of 205 positive samples (group III) showed a clearly
Figure 1 Silver stained SDS-PAGE gel. Silver stain of SDS-PAGE of
mixtures of purified LPS of B. mallei strains protein standard (lane 1),
Mukteswar (lane 2); Bogor (lane 3); Zagreb (lane 4), mixture of all
(lane 5).
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Page 3 of 6visible LPS banding pattern and were scored positive. A
panel of immunoblot strips of samples from Pakistan
are shown in Figure 3. On this basis, the diagnostic sen-
sitivity and specificity of the Western blot was calculated
to be 100%. CFT false positive samples (n = 70) from
group I were also tested negative.
Rabbit hyperimmune sera against B. cepacia and
P. aeruginosa showed no clearly visible LPS banding
pattern. Only the anti- B. pseudomallei serum cross
reacted with the B. mallei antigen in the Western blot
assay (Figure 4).
Discussion
Following eradication of glanders from the Western
hemisphere, false positive CFT results pose a consider-
able problem in trade of equids. The need for the devel-
opment and evaluation of highly specific serological
tests for exclusion of false positive results became
imperative. One competitive ELISA (cELISA) was
described based on mallein as antigen and an in house
monoclonal antibody (mAb) [22]. Another cELISA used
a commercially available B. mallei specific mAb (3D11)
and a simple carbohydrate preparation of B. mallei as
antigen [20]. Both tests show comparable sensitivity
(98.9% and 98.6%, respectively) and a specificity of
100%. Due to the sophisticated technique, the high costs
for mallein and mAbs and the restricted availability of
t h e s em A b s ,t h ec E L I S A sw i l ln o tb ea v a i l a b l ef o r
routine laboratories in the future. Other tests still used
for diagnosing glanders are Rose Bengal agglutination
test, indirect hemagglutination test, counter immunoe-
lectrophoresis and indirect fluorescent antibody test
[21,25-29] which have either technical shortcomings or
have low specificity and/or sensitivity. New approaches
Figure 2 Score of immunoblot. Score of immunoblot: lane 1:
negative, lane 2: suspicious, lane 3: positive.
Figure 3 Western blot analysis of sera from Pakistan. Lane 1:
negative control; lane 2: positive control; lane 3-12 sera of acutely
infected horses from Pakistan.
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glanders and melioidosis are based on polysaccharide
antigens [30] but these techniques are expensive and
not suited for routine mass testing of sera.
The CFT is used for diagnosis of many diseases world-
wide and has a high sensitivity, especially when used for
glanders serodiagnosis. This finding was again demon-
strated by our study. We conclude therefore that the
CFT is still the most valuable screening test currently
available. But again, the CFT had a specificity of only
94.5% in a set of horse sera from a glanders free region
(Germany). Consequently, a considerable number of
CFT false positive tested animals must be expected
when horses from glanders free regions are tested by
the current OIE standards [6]. The need of the develop-
ment of a supplementary confirmatory test with a high
negative likelihood ratio for international trade was
stressed again.
B. mallei LPS-based Western blot assays are cheap,
easy to produce and user friendly test systems which
have been developed in the past, but could not be evalu-
ated on a significant number of positive and negative
horse sera until now [12]. We were able to collect 205
sera of infected animals from geographically different
regions and a set of sera from immunized animals
(horse and rabbit), enabling us to validate the Western
blot assay for its use in the routine serodiagnosis of
glanders.
It was proven that the Western blot technique is
highly specific and is able to supplement the CFT to
avoid false positive diagnoses in horses and mules. The
advance of the immunoblot technique is that specific
bands can be distinguished from background reactions
in contrast to the CFT. The investigation of the hyper-
immune sera of rabbits against B. mallei LPS showed
that B. cepacia and P. aeruginosa won’ti n t e r f e r ew i t h
this technique. B. pseudomallei antibodies, however, will
cause false positive results due to known cross-reacting
epitopes of the LPS [31,32]. In international trade, it is
also of utmost importance not to transport animals
infected with the dangerous zoonotic agent B. pseudo-
mallei from endemic areas to areas with ambient envir-
onment where B. pseudomallei could establish a
temporal or permanent reservoir. An identification and
destruction of those animals will have an additional zoo-
sanitary and ecological benefit.
Conclusions
The developed method of LPS-preparation reported
here is highly feasible and cheap. The qualitative and
quantitative composition of our antigen proofed to be
suitable for its use in immunobloting. The developed
method is a highly sensitive and specific serological test
for glanders diagnosis. It will be of great value in glan-
ders endemic areas in less developed countries.
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